Search International and National Patent Collections
|1. (WO2018089328) TREATMENT OF CNS DISEASES WITH SGC STIMULATORS|
|Applicants:||IRONWOOD PHARMACEUTICALS, INC.
LEE, Thomas, Wai-ho
IYENGAR, Rajesh, R.
PERL, Nicholas, Robert
RIBADENEIRA, Maria, D.
|Title:||TREATMENT OF CNS DISEASES WITH SGC STIMULATORS|
The present disclosure relates to the use of stimulators of soluble guanylate cyclase (sGC), pharmaceutically acceptable salts thereof and pharmaceutical formulations or dosage forms comprising them, alone or in combination with one or more additional agents, for the treatment of various CNS diseases, wherein an increase in sGC stimulation, or an increase in the concentration of nitric oxide (NO), or cyclic guanosine 3',5'-monophosphate (cGMP) or both, or an upregulation of the NO pathway is desirable.